Our website does not support this browser  

Cerebral Palsy

Cerebral Palsy
Cerebral palsy is a group of permanent developmental disorders that affect movement and posture. These disorders are most likely caused by disturbances in the development of the brain at fetal or infant stage. The motor disorders of cerebral palsy are often accompanied by issues with sensation, perception, cognition, communication and behavior by epilepsy, and by secondary musculoskeletal problems.

There are many different types of Cerebral Palsy, which vary in the parts of the body that are affected, the type of impairment and the severity of mobility limitations.

Cerebral Palsy has a major impact on the child’s and caregiver’s quality of life. Caregivers are under a lot of pressure, and implications can affect their overall quality of life. Our goal is to provide specifically designed product ranges and services to help caregivers and patients overcome such challenges and improve their daily lives both physically and emotionally.

Read more about my child with cerebal palsy
Page Title
What is cerebral palsy?

Pediatric Food Allergies

Pediatric Food Allergies
CMPA is one of the most common food allergies in infancy, caused by an abnormal immune response to proteins found in cow's milk. It's also associated with increased gut permeability and altered gut microbiota. It can affect how a child's immune system matures, increasing the risk of developing further allergies down the line.

Our range of nutritional solutions—Althéra HMO, Alfare HMO, Alfamino HMO and Alfamino Junior HMO—are tailor-made for infants and young children with mild to severe CMPA, as well as more complex multiple food allergies. We've carefully designed the range to help parents and healthcare professionals manage CMPA with the right product from the beginning.

Our range of extensively hydrolyzed formulas and amino acid-based formulas are also the first to contain 2'-fucosyllactose (2’FL) and lacto-N-neotetraose (LNnT), two human milk oligosaccharides structurally identical to those found in breastmilk (not sourced from breastmilk). HMO are potentially valuable components to support the immune system of the most vulnerable infants with CMPA.

Read more about Cow’s milk protein allergy (CMPA)
Page Title
Nutrition for infants and children with cow's milk protein allergy (CMPA)

Oncology

Oncology
Malnutrition and a loss of muscle mass are frequent in cancer patients and have a negative effect on clinical outcome. This may be driven by inadequate food intake, decreased physical activity and catabolic metabolic derangements. To screen for, prevent, assess in detail, monitor and treat malnutrition, standard operating procedures with responsibilities, and a quality control process should be established at each institution involved in treating cancer patients. ​

Nestlé Health Science, a leader in science-based nutritional innovations, works together with patients with cancer, their caregivers, and healthcare professionals to develop specific nutritional products designed to provide nutritional support for patients who experience certain side effects of cancer treatment, such as oral discomfort and taste changes.
Page Title
Using nutrition to help cancer patients

Malnutrition

Malnutrition
Malnutrition is a health issue of global dimension, which also affects developed countries. Population subgroups at risk of malnutrition include hospitalised adults, older adults, adults with a poor mental health status, patients with one or more medical condition, etc.

In the elderly, there are many factors that cause people to become malnourished: loss of appetite, difficulties with eating (preparing or cutting up food), chewing (e.g. ill-fitting dentures, dry mouth) and/or swallowing (dysphagia), smell and taste reduction, and other medical conditions that cause nutrient malabsorption or a person to eat less. The risks of malnutrition are serious and include an increased chance of infection, slower recovery from illness or injury and overall increased mortality. A systematic screening and the use of individualised nutritional support, including Oral Nutritional Supplements (ONS) were demonstrated to improve energy and protein intake and significantly reduce mortality and complication rates in malnourished medical inpatients.

Malnutrition is also one of the most common and most serious side effects of cancer and its treatment. The prevalence of malnutrition in cancer patients ranges from about 20% to more than 70%. However, 10–20% of cancer patients’ deaths are related to malnutrition, not the malignancy itself. To prevent weight loss, improve the patients’ quality of life, reduce the treatment toxicity, and the risk of mortality, the diagnosis and screening of malnutrition should be made as early as possible to facilitate the best possible treatment. ​

When faced with the risk of nutritional deficiency during childhood, intervention is advised to support and maximize a child’s full potential. Oral nutritional supplements can help children catch up: improve body weight, growth and development. Nutren® Junior has been scientifically designed to help a child get back and stay on track to reach full potential with the B.I.G formula.​

Our high range and delicious tasty oral nutritional supplements —Resource®, Nutren®, Boost®, Clinutren®, Meritene® — are ideally placed to fulfil the needs of individuals with (risk of) malnutrition and deliver the clinical and economic benefits associated with ONS use. ​
Tool and Resource
Image
Malnutrition_Find your MNA Form
Title
Malnutrition Find your MNA Form
HCP Content
Off
Page Title
Malnutrition occurs more often in the elderly, but not only

Inflammatory Bowel Conditions

Inflammatory Bowel Conditions
IBD is a group of diseases where the gastrointestinal tract is chronically inflamed. Symptoms can appear episodically or persistently and make it hard to carry out everyday activities. The most common forms of IBD are Crohn’s disease and ulcerative colitis.

No single cause of IBD has been identified. Genetics, our immune system, our intestinal microbiota and the environment that we live in can all play a role. IBD symptoms can be affected by diet and stress, so lifestyle and nutritional changes can help. That's why our teams devote significant resources to the research and development of nutritional therapies for gastrointestinal disorders, including IBD. We hope, in this way, we can help patients better live with their condition.

We have pioneered the field of dietary management of CD with various effective solutions from exclusive enteral nutrition to partial enteral nutrition and more recently Crohn’s Disease Exclusion Diet (CDED) through the very unique ModuLife program. More recently we are engaged to complete our proposition by developing new diet solution for UC.
Page Title
What is inflammatory bowel disease (IBD)?

Enteral Feeding

Enteral Feeding
Enteral feeding is a form of nutritional support when a patient with a working digestive system is unable to eat or drink. Food is administered via a tube through the nose or a stoma placed into the stomach or small intestine.

Enteral nutrition is widely used as it's simpler and more substantial than parenteral nutrition (i.e. nutrition administered via a drip).

With expertise from brands like Isosource, Novasource and Peptamen we are able to provide science-based, clinically proven enteral nutritional solutions to meet the needs of a wide range of patients, from short- to long-term care both in hospital and at home.

Read more about enteral nutrition
Page Title
Understanding enteral nutrition

Dysphagia

Dysphagia and Reflux
Dysphagia is the term used to describe difficulty in swallowing, that has devastating consequences, such as malnutrition, dehydration and aspiration pneumonia. This symptom is a highly prevalent co-morbidity among patients suffering from a range of conditions including stroke, neurodegenerative diseases, patients treated for head and neck cancer, and among older adults. Dysphagia generally occurs in all age groups, including pediatric patients.​

Thickening liquids and food texture modification is an effective and safe method of improving patients’ swallowing ability, improving nutritional intake and reducing the risk of aspiration.​

Our range of nutritional solutions such as ThickenUp Junior, ThickenUp and ThickenUp Clear for pediatrics and adults, as well as our Texture Modified Food products, are tailored-made to improve swallowing function and decrease the risk of complications of dysphagia.​

We are engaged in promoting The International Dysphagia Diet Standardization Initiative (IDDSI) framework terminology and support its development across the world, in all care settings and for all cultures.
Page Title
Understanding dysphagia

Diabetes

Diabetes
Affecting 463 million people worldwide, diabetes is a chronic disease that affects the body's ability to produce insulin or use it properly—leading to high glucose levels in blood.

Type 2 diabetes is the most common form, accounting for around 90% of all cases. There are several factors that contribute to the development of diabetes such as excess body weight and physical inactivity, which make the body resistant to to using its own insulin. If blood sugar levels are left unchecked, patients can develop conditions like hypertension, high cholesterol and cardiovascular disease. All of which bring their own health risks and challenges.

There is also a stage called prediabetes—where blood sugar levels are higher than normal, but not enough to be diagnosed as type 2 diabetes. By identifying and managing this stage, you can reduce the likelihood of progressing to type 2 diabetes.
Page Title
What is diabetes?

Cystic Fibrosis

Cystic Fibrosis
CF is an inherited disorder that severely damages the lungs, digestive system and other organs. CF affects the cells that produce mucus, sweat and digestive juices, causing the fluids to become viscous and sticky, as opposed to lubricating. This causes the secretions to block tubes, ducts and passages—especially in the lungs and pancreas.

Although CF is progressive and needs daily care, people with the condition are usually able to attend school and work. Advances in screening, treatment and nutritional management over the last few decades have contributed to improvements in clinical outcomes, quality of life, and life expectancy.

Since our first solution offerings with Peptamen, we have continued engaging in innovation to develop new generation of formulas with an exclusively licensed pre-digested fat component specifically designed for pancreatic insufficient patients.
Page Title
What is cystic fibrosis (CF)?